Scientific journal
European Student Scientific Journal
ISSN 2310-3094
ISSN 2310-3094
HERCEPTIN IN THE TREATMENT OF BREAST CANCER
137 KB
Breast cancer is the most prevalent type of cancer amid women in Europe. The main problem in the treatement of this type of cancer are the remaining blood circulating cancer cells after the surgical removing of tumor. These cells are determined to be the targets of the adjuvant therapy of breast cancer. Herceptin (Trastuzumab) is used to conduct this therapy. This remedy blocks human epidermal growth factor receptors (HER) on tumors. Modern science knows more than 20 HERs of different types. The most unfavorable sign of the disease development is HER-1 and HER-2 coexpression. Herceptin showed its efficacy in breast cancer treatement. Its influence is based on HER-2 block. Also researches are held to study the possibility of combining Herceptine with other drugs.
breast cancer
Herceptin
epidermal growth factor receptor